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Depressive Symptoms, Substance Use and Partner Violence 
Victimization Associated with HIV Disclosure among Men who 
have Sex with Men
Monique J. Brown, Julianne M. Serovich, and Judy A. Kimberly
College of Behavioral and Community Sciences, University of South Florida, Tampa, FL
Abstract
HIV continues to disproportionately affect men who have sex with men (MSM). Depression and 
substance use have been shown to be risk factors of partner violence among male same-sex 
couples. However, research exploring the risk factors for partner violence victimization after HIV 
disclosure among MSM is limited. The aim of this study was to determine the association between 
depressive symptoms, substance use, and disclosure-associated verbal and/or physical violence 
from a partner among MSM. Data were obtained from 340 HIV-positive MSM. Multivariable 
logistic regression was used to determine the associations between Center for Epidemiologic 
Studies-Depression (CES-D) and substance use scores, and disclosure-associated partner violence. 
After adjusting for age and income, every one-unit increase in substance use scores resulted in a 
9% (OR=1.09; 95% CI: 1.01 – 1.16) increase in the odds of disclosure-associated partner violence. 
HIV disclosure interventions for MSM populations should address substance use and potential 
violence from partners after disclosure.
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Introduction
HIV continues to disproportionately affect men who have sex with men (MSM) compared to 
any other group globally [1] and in the US [2]. MSM populations represent about 2% of the 
US population but account for approximately six in ten (63%) of the estimated new 
infections in the US and close to eight in ten (78%) of all men who have been newly 
diagnosed with HIV [2]. In 2011, the majority of persons living with HIV were MSM who 
were also injection-drug users [2]. With the high rates of HIV among MSM populations, 
disclosure of HIV status to partners becomes an integral factor in the prevention and 
treatment of HIV [3].
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Disclosure of HIV status to partners may have numerous benefits. Increasing awareness of 
risk may help to motivate partners to seek HIV testing, reduce risky sexual behaviors, and 
decrease HIV transmission [4]. Benefits to the individual who discloses may include social, 
physical, psychological dividends [5] such as social support, better access to HIV treatment 
and care, and increased opportunities to discuss the reduction of HIV risk with partners [4]. 
Nevertheless, the decision to disclose HIV status to partners may have implications in all 
arenas of life [6]. The Consequences Theory of HIV disclosure states that people with HIV 
are likely to disclose their status to partners if the benefits or rewards for disclosing their 
status outweigh the costs or risks [5]. Costs may include valuable things that are given up for 
a reward of greater or equal value, or consequences that would be otherwise avoided [5], 
such as blame, abandonment, discrimination, disruption of relationships and physical and/or 
emotional abuse [4].
Partner violence continues to be a major public health problem in the US [7]. Violence 
between partners is not only a public health issue among heterosexual couples but also 
among same-sex couples [7,8], and is sometimes found to be more prevalent among same-
sex couples compared to heterosexual couples [9–11]. Among younger populations with 
same-sex partners, partner violence is also commonplace with one in four adolescents from 
a population-based sample reporting partner violence victimization, and approximately one 
in ten reporting physical partner violence [12]. Among a sample of MSM in the Chicago 
area, approximately 32% reported partner violence, 21% reported a history of verbal abuse, 
19% reported physical abuse and 19% reported sexual abuse. The majority of men reporting 
any partner violence reported experiencing more than one type of partner violence [13], 
which highlights the interconnectivity of different forms of partner violence. Among a 
probability-based sample of MSM living in four US cities (Chicago, Los Angeles, New 
York, and San Francisco), 34% reported psychological partner violence, 22% reported 
physical partner violence and 5% reported sexual partner violence [9]. Risky sexual 
behavior, such as unprotected anal sex [13], younger age [9], lower education level [9], 
being HIV-positive [9], experiencing depression [13] and substance abuse [13,14] have been 
shown to be risk factors for partner violence among MSM populations.
The association between depressive symptoms, substance use and partner violence is 
complex. Several studies have shown a link between depression [15,16], substance use and 
abuse [17–20], and other mental health disorders [21,22] and partner violence among men 
and women. However, specifically among MSM couples, methamphetamine use, rock or 
crack cocaine use, and heavy drinking have been associated with partner violence 
victimization and aggression [14]. Alcohol intoxication, substance use problems including 
substance use with sex, hard drug use, and mental health diagnoses (including depression, 
bipolar disorder, and any psychiatric/emotional disorders) have also been associated with 
partner violence among MSM populations [13].
Theoretically, the psychoactive effects from the use of substances, such as impaired 
judgment, and having depressive symptoms may be related to partner violence victimization 
associated with HIV disclosure in a number of ways. Impairment from substance use may 
result in poorly timed or inappropriately delivered information on HIV serostatus to a 
partner based on poor judgement. For example, being under the influence of substances is 
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likely to prohibit the accurate reading of a partner’s possible negative reaction to such 
sensitive information. It is equally likely that cognitive impairment may lead to the inability 
to leave a violent situation. Depressive symptoms may be associated with disclosure-
associated partner violence due to the indifference a person may feel towards leaving a 
violent situation. For example, a history of depression may be associated with placing 
elevated focus on a maintenance of a relationship with a partner, [23] albeit casual. As a 
result, an individual may be more willing to tolerate violence [23] from his partner.
As previously stated, one potential cost of disclosing HIV status to a partner is violence. 
Theoretically, among individuals with casual sex partners, the violence that may occur after 
disclosing their serostatus could be due to a reaction out of fear from their sex partners that 
they were put at risk of contracting HIV and even more so fearful that transmission of HIV 
may have occurred. Nevertheless, research focusing on HIV-disclosure associated partner 
violence tend to concentrate on women. These studies have shown that women experience 
abuse (sexual, physical and/or emotional) directly related to HIV disclosure or that occurred 
only after their HIV serostatus was disclosed [3,24–27]. For example, Shamu and colleagues 
[3] explored disclosure-associated partner violence among pregnant women in Harare, 
Zimbabwe and showed that gender inequity, history of partner violence, risky sexual 
behaviors were associated with partner violence after HIV disclosure. Positive HIV status 
was linked to partner violence and negative reactions by male partners immediately after 
disclosing HIV status [3]. Among this population, the study showed the interconnectivity of 
partner violence, HIV status and HIV disclosure. Populations at risk for partner violence 
tend to be the same groups at risk for HIV infection [26]. However, studies examining risk 
factors for violence associated with disclosure of HIV status among sexual minority 
populations are lacking. Research exploring the interconnectivity between depressive 
symptoms, substance use and partner violence after HIV disclosure specifically among 
MSM populations is extremely limited. To our knowledge, no study has examined potential 
risk factors for partner violence associated with HIV disclosure among sexual minority 
populations. The objective of this study was to explore the association between depressive 
symptoms, substance use, and verbal and/or physical abuse by a partner associated with 
disclosure of HIV status among MSM. Determination of risk factors for violence associated 
with disclosure of HIV status to partners is crucial. As a result, public health practitioners, 
and health care providers of MSM populations living with HIV may be aware of these 
factors, and incorporate the necessary resources to address the interconnectivity of 
depressive symptoms, substance use and abuse associated with disclosure of status to 
partners, especially among MSM populations. We hypothesize that men who abuse 
substances and/or have depressive symptoms may be more likely to experience violence 
after disclosing their HIV status to their partners.
Methods
Data were obtained from 340 participants at the baseline assessment of a longitudinal 
randomized-controlled trial of an intervention designed to assist HIV-positive MSM in 
disclosing their serostatus to casual sex partners. This disclosure intervention study was 
conducted across two metropolitan statistical areas (MSA; Columbus, Ohio and Tampa, 
Florida) from December, 2009 through December, 2014 and consisted of participants who 
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were HIV-positive, at least 18 years old, were sexually active, had two or more partners in 
the last 12 months (at least one of which was a man), and indicated an interest in learning 
more about disclosing their serostatus to sexual partners. In addition, men were English 
speaking and planned on living in the MSA for at least one year. Separate IRB approval was 
garnered for both recruitment locations and participants were treated in accordance with the 
“Ethical Principals of Psychologists and Code of Conduct” [28].
Study Participants and Recruitment
The average age of participants (n = 340) was 42.1 years (SD = 11.03 years). The average 
time since diagnosis was 13.6 years (SD = 8.3). Self-reported sexual orientation was mostly 
gay (n = 267, 78.5%), and 74.4% (n = 253) indicated that they had sex only with men. Most 
participants reported being single (n = 238, 70%). Across study sites, there were statistically 
significant differences by age where the mean age of men from Tampa was 44.5 years (SD = 
10.3) and from Columbus, 39.5 years (SD = 11.2). There were also statistically significant 
differences in substance use scores where the mean score among men from Tampa was 13.0 
(SD = 5.7) and from Columbus, 14.9 (SD = 5.7). There were no statistically significant 
differences by income, race/ethnicity, educational level, employment status, CES-D score 
and partner violence status.
Participants were recruited in several ways. First, individuals were recruited through 
advertising efforts with local/state AIDS service organizations (ASOs). Caseworkers were 
informed about the study and handouts were made available to distribute to potential 
participants or through newsletters and direct mailings. ASOs also featured calls for 
participation on their websites, and sent materials to clients for recruitment efforts. 
Recruitment materials were also placed at HIV-related venues and forums held throughout 
the MSAs, and at local eating and drinking establishments. Finally, advertisements were 
placed in local daily newspapers.
Data Collection
Prior to randomization, participants completed a baseline questionnaire administered using 
audio-computer assisted self-interviewing (ACASI). Social desirability has been identified 
as a potential problem in the collection of reliable data on serostatus disclosure [29,30]. 
However, ACASI has been demonstrated to be associated with more complete reporting of 
potentially stigmatized drug, sex and HIV risk behaviors [31,32]. Additionally, ACASI has 
been both accepted and preferred as a method of data collection by participants in HIV risk-
related studies [32]. Data were collected on person-level characteristics (i.e., items and 
scales asked only once for each participant) and encounter-level characteristics (i.e., 
repeated measures for each participant). Personal-level items included measures of 
demographic characteristics, global sexual/disclosure activities (i.e., count measures of 
specific activities during the prior 30 days), and measures relevant to sexual activity/
disclosure.
Measures
Verbal and/or Physical Abuse associated with Disclosure—Verbal and/or 
physical abuse associated with disclosure was measured using a single item: “In the last 30 
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days, how many times were you verbally or physically abused by a partner after 
disclosing?” Approximately 99.4% of participants (338/340) answered this item, with 
responses ranging from 0 to 10, with an average of 0.19 times.
Depressive symptoms—Depressive symptoms were measured using the Center for 
Epidemiologic Studies-Depressed Mood (CES-D) [33] scale, which is a 20 item scale used 
to measure depressive symptoms in the general population. Items were scored using a 4-
point Likert-type scale with values ranging from Rarely or None of the time (0) to Most or 
All of the time (3). Scores were summed to arrive at an overall score with values ranging 
from 0 to 60, with higher scores indicative of more depressive symptoms. The CES-D was 
chosen because of its good reported internal consistency (α = 0.85) and validity [33]. 
Depressive symptoms were also examined as a binary variable to determine participants 
who were at risk for clinical depression (CES-D ≥ 16) [34]. For the current study, the 
standardized Cronbach’s α for the CES-D was 0.94.
Substance Use—To assess substance use participants completed the substance use items 
of the Substance Abuse and Mental Illness Symptoms Screener (SAMISS) [35]. These seven 
items inquired about participants’ frequency, amount, and perceived problematic use of 
alcohol, illicit drugs, and prescription drugs and were summed to derive an overall substance 
abuse score. For most of the items, a Likert-type response scale ranging from Never (1) to 4 
or more times a week (5) was used. Specific items were then summed to determine whether 
the participant was considered positive for substance use problems if their score exceeded a 
specified threshold [35]. For the current study, the standardized Cronbach’s α for the 
SAMISS was 0.77.
Potential Confounders
Confounders considered were shown to be associated with depression and substance use, 
and partner violence based on literature review a priori. Statistically significant differences 
in sociodemographic characteristics such as age [36–38] and income [37] are associated 
with depression. Substance use has also been shown to differ by age [39–44] and income 
[41,43]. Previous studies have shown differences in age [45,46] and income [45,47] to be 
linked to partner violence. Therefore, the current study considered age (continuous) and 
monthly income ($0 to $500, $501 to $1,000, ≥$1001) as potential confounders.
Analytic Approach
Participants were excluded if they were missing on all depressive symptoms, substance use, 
and partner violence questions (n = 2). The resultant sample size was 338.
Descriptive statistics were used to determine the distribution of sociodemographic 
characteristics among men reporting and not reporting partner violence after HIV disclosure. 
Two sets of multivariable logistic regression models were used to obtain adjusted odds ratios 
and 95% confidence intervals depicting the association between depressive symptoms, 
substance abuse, and partner violence after disclosure of HIV status. Each confounder was 
placed in different models with depressive symptoms, and substance use as separate 
exposure variables, and partner violence victimization after disclosure as the outcome. 
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However, no confounder changed the effect estimate between depressive symptoms, 
substance use and partner violence victimization >10%. Nevertheless, adjusted models were 
still examined as recent research has recommended that potential confounding variables 
should not be discarded based on a lack of change in estimates but should still be included in 
the model based on theoretical evidence [48]. As a result, three nested models were used for 
each exposure measure: (1) an unadjusted model, (2) a model adjusted for age, and (3) a 
model adjusted for age and income. Exact logistic regression was used to assess the 
association between depressive symptoms and substance use as binary variables (where 
more information would be lost compared to analyzing them as continuous scores), and 
verbal and/or physical abuse associated with HIV disclosure. All analyses were performed 
with SAS software Version 9.4 (SAS Institute, Cary, NC).
Results
The distribution of sociodemographic characteristics, verbal and/or physical abuse by an 
intimate partner, depressive symptoms, and substance use among the study population 
overall, and by partner violence status are presented in Table 1. In the past 30 days, 6.2% of 
the population reported partner violence victimization after disclosing their HIV serostatus 
to a partner. Approximately six in ten respondents were at risk for clinical depression 
(58.6%) and seven in ten reported substance use (72.2%). The mean score for depressive 
symptoms was 20.4 (SD = 13.3) and the mean substance use score was 13.9 (SD = 5.8). 
Seven in ten (71.4%) respondents reporting verbal and/or physical abuse by a partner and 
close to six in ten (57.7%) not reporting disclosure-associated partner violence in the past 30 
days were at risk for clinical depression. Approximately 90.5% of the sample reporting 
disclosure-associated partner violence and 71.0% of the sample not reporting disclosure-
associated partner violence met the Whetten criteria [34] for substance use. Mean CES-D 
scores were 27.6 (SD = 13.7) and 20.0 (SD = 13.1) for participants reporting disclosure-
associated partner violence and not reporting disclosure-associated partner violence, 
respectively. Mean substance use scores were 17.5 (SD = 6.7) among victims of disclosure-
associated partner violence in the past 30 days and 13.7 (SD = 5.7) among participants not 
reporting disclosure-associated partner violence.
Logistic regression analyses depicting the association between depressive symptoms and 
substance use sum scores, and verbal and/or physical abuse by a partner associated with 
disclosure in the past 30 days are shown in Table 2. Separate crude models show that for 
every one-unit increase in depressive symptoms and substance use scores, there was a 4% 
increase (OR: 1.04; 95% CI: 1.01 – 1.08) and 10% increase (OR: 1.03; 95% CI: 1.03 – 1.18) 
in the odds of reporting verbal and/or physical abuse by a partner after disclosing HIV 
serostatus. In other words, the more someone was depressed or increased their substance 
use, the likelihood of experiencing verbal and/or physical abuse by a partner after disclosing 
their HIV status increased 4% and 10%, respectively. After adjusting for age and income, 
the relationship between depressive symptoms and disclosure-associated partner violence 
was attenuated so that the confidence intervals included unity (OR: 1.03; 95% CI: 0.99 – 
1.07). However, the association between substance use and disclosure-associated partner 
violence remained statistically significant (OR: 1.09; 95% CI: 1.01 – 1.16).
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Table 3 shows the results of exact logistic regression analyses depicting the association 
between being at risk for clinical depression, and substance use, and verbal and/or physical 
abuse by a partner after disclosing serostatus in the past 30 days. There were no statistically 
significant associations.
Discussion
This study is the first to demonstrate an association between depressive symptoms, 
substance use, and experiencing verbal and/or physical abuse associated with disclosure of 
HIV serostatus. In the full models, substance use scores were statistically significantly 
associated with disclosure-associated partner violence, but no relationship was seen between 
depressive symptoms and disclosure-associated partner violence. Associations between 
binary representations of being at risk for clinical depression, substance use and disclosure-
associated partner violence were not statistically significant.
The results from the current study depicting a relationship between substance use and 
disclosure-associated partner violence supports findings from previous researchers 
examining the link between substance use and partner violence, and confirms part of our 
hypothesis. Wu et al. showed that substance use, specifically heavy drinking and 
methamphetamine use, was linked to partner violence among Black MSM throughout the 
relationship period and in the past month [14]. However, the same study found that cocaine 
use was statistically significantly associated with lifetime partner violence but not partner 
violence in the past month. Tran et al. found that substance use, including ecstasy, cocaine, 
and methamphetamine use, was also linked to partner violence among Asian/Pacific Islander 
MSM [49]. The lack of statistically significant associations between substance use as a 
binary variable and disclosure-associated partner violence could have been due to the small 
cell sizes as a result of the small number of participants reporting verbal and/or physical 
abuse associated with disclosure in the past 30 days. Categorizing continuous variables into 
binary variables may result in loss of information, which in this case, due to small numbers, 
may also contribute to failure to reject the null hypothesis.
Substance use may be associated with verbal and/or physical abuse by a partner after 
disclosure for a number of reasons. As previously theorized, substance use may be 
associated with disclosure-associated partner violence due to psychoactive effects of 
substance use and/or abuse leading to impaired judgment; and/or the inability to leave a 
violent situation. Therefore, men with substance use may be more likely to be vulnerable 
and more susceptible to verbal and/or physical abuse by a partner after disclosing their HIV 
serostatus compared to men who do not use substances.
Depressive symptoms were not statistically significantly associated with verbal and/or 
physical abuse by a partner after disclosure, which contradicts our hypothesis. This finding 
suggests that depressive symptoms might not play a role in disclosure-associated partner 
violence from casual partners among MSM. The current findings contradicts other studies, 
which have shown that depressive symptoms are associated with partner violence 
[13,15,16,50]. Nevertheless, these studies examined depression and partner violence among 
women [50,51], and heterosexual couples [16]. This difference in findings could be due to 
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differences in study populations. Houston and McKirnan examined risk factors of intimate 
partner abuse among MSM and found that substance abuse and depression were associated 
with sexual and/or physical and/or verbal abuse [13]. However, their study examined sexual, 
physical and verbal abuse, not associated with disclosure of HIV status.
The findings of this study should be considered with some limitations. First, the total sample 
size was small with only 21 respondents responding to experiencing verbal and/or physical 
abuse by a partner after HIV disclosure in the past 30 days. As a result, large confidence 
intervals were obtained for analyses examining depressive symptoms and substance abuse as 
binary variables, and results implied that the null hypothesis could not be rejected. Also, due 
to the small sample size, the most parsimonious model (adjusting for age and income) was 
used and did not include other covariates in the model. We did not adjust for other 
sociodemographic characteristics, and for substance use when using depressive symptoms as 
an outcome, or for depressive symptoms when using substance use as the outcome. Indeed, 
adjusting for one factor, which is the outcome in another model with the same confounders 
may lead to circular analysis [52]. Second, verbal and/or physical abuse by a partner 
associated with HIV disclosure was only reported in the past 30 days. Disclosure-associated 
partner violence in the past month may not be representative of partner violence after 
disclosure at other time points. Varying relationships have been found between substance 
use and partner violence during the relationship period and partner violence in the past-
month [14]. Third, it is possible that there may be shifts in the impact of variables or 
intervening variables over the study period (2009 to 2014). As a result, relationships among 
variables may change overtime. Therefore, longitudinal studies collecting data on depressive 
symptoms and substance use with follow-up data collection on partner violence are 
warranted to help to mitigate the shifts in variable impact that may change overtime in a 
cross-sectional study design, and to compare to findings seen in the current study. Fourth, 
the relationship between depressive symptoms, substance use, and partner violence may 
have differed across study sites. Indeed, substance use was statistically different across study 
sites. However, we were unable to determine differences and/or similarities in relationships 
across study sites due to the small number of participants reporting verbal and/or physical 
abuse from a partner. Fifth, the question asking study participants about disclosure-
associated partner violence did not ask for information on sexual violence, which has been 
linked to alcohol and drug problems through posttraumatic stress symptom severity [53], 
and to depression through avoidance coping [54].
Nevertheless, the current study had several strengths. This study was the first to examine the 
association between depressive symptoms, substance use, and disclosure-associated violence 
among MSM. Depressive symptoms and substance use were operationalized as binary and 
continuous variables. These definitions allowed for analysis of binary variables based on 
previously defined thresholds, and of continuous variables so as not to lose any information 
in analysis. Next, nested models accounting for multiple potential confounders were used. 
The use of nested models helps to determine the change in effect estimates depending on 
what confounders were adjusted for at each stage. A final strength of this study was the use 
of exact logistic regression models. This technique accounted for the small cell sizes in 
models using the binary variables for depressive symptoms and substance use for analysis.
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Conclusions
HIV disclosure interventions geared towards MSM populations should include resources to 
address substance use and partner violence victimization. Nevertheless, the findings also 
suggest that interventions for substance use should also address verbal and/or physical abuse 
by a partner associated with disclosure of HIV status among MSM populations. Health care 
providers, especially for populations living with HIV, should also be aware of the 
association between substance use and disclosure-associated violence so they may provide 
resources addressing not only substance use, but also violence prevention to persons who 
want to disclose their status to an intimate partner. Given the prevalence of substance use 
and depressive symptoms experienced by MSM (as demonstrated in this sample), the 
inclusion of these variables in future studies with this population is warranted. In light of the 
current study findings, future researchers should address the link between other mental 
health measures such as anxiety, PTSD, and disclosure-associated violence victimization 
among MSM populations. Future researchers may also wish to assess partner violence 
experienced over time, specifically include sexual violence as part of their measures, and use 
larger sample sizes when possible.
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Table 1
Sociodemographic Characteristics, Depressive Symptoms, and Substance Use Overall and by Partner 
Violence Associated with Disclosure in Study Sample
Overall
N=338
N (%)
Partner
Violence
N=21
N (%)
No
Partner
Violence
N=317
N (%)
p-valuea,b
Age (Mean, SD) 42.1, 11.0 39.4, 10.8 42.3, 11.0 0.243
Monthly Income
  $0 to $500 102 (30.2) 12 (57.1) 90 (28.4)
  $501 to $1,000 96 (28.4) 6 (28.6) 90 (28.4)
  ≥$1,001 140 (41.4) 3 (14.3) 137 (43.2) 0.009
Race/Ethnicity
  Black 180 (53.3) 9 (42.9) 124 (39.1)
  White 133 (39.4) 10 (47.6) 170 (53.6)
  Other 25 (7.4) 2 (9.5) 23 (7.3) 0.843
Education
  Less than high school 35 (10.4) 4 (19.1) 31 (9.8)
  High school 79 (23.4) 8 (38.1) 71 (22.4)
  At least some college 224 (66.3) 9 (42.9) 215 (67.8) 0.062
Employment
  Yes 103 (30.5) 3 (14.3) 100 (31.6)
  No 235 (69.5) 18 (85.7) 217 (68.5) 0.096
Depression Score (Mean, SD) 20.4, 13.3 27.6, 13.7 20.0, 13.1 0.010
Clinical Depression
  Yes 198 (58.6) 15 (71.4) 183 (57.7)
  No 140 (41.2) 6 (28.6) 134 (42.3) 0.217
Substance Use Score (Mean, SD) 13.9, 5.8 17.5, 6.7 13.7, 5.7 0.004
Substance Use (Whetten)
  Yes 244 (72.2) 19 (90.5) 225 (71.0)
  No 94 (27.8) 2 (9.5) 92 (29.0) p < 0.001
a
P-value compares participants reporting and not reporting partner violence associated with HIV disclosure in the past 30 days.
bChi-square test used for categorical variables and pooled t-test used for continuous variables.
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Table 2
Logistic Regression Analyses Depicting the Association between Depressive Symptoms, and Substance Use 
Sum Scores, and Partner Violence associated with Disclosure
Model 1a Model 2b Model 3c
OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
Depression Sum Score 1.04 (1.01 – 1.08) 1.04 (1.01 – 1.08) 1.03 (0.99 – 1.07)
Substance Use Score 1.10 (1.03 – 1.18) 1.10 (1.02 – 1.18) 1.09 (1.01 – 1.16)
Bolded odds ratios and 95% confidence intervals are statistically significant at p = 0.05
a
Model 1: unadjusted
b
Model 2: adjusted for age
c
Model 3: adjusted for age and income
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Table 3
Exact Logistic Regression Analysis Depicting the Association between Being at Risk for Clinical Depression 
and Substance Use, and Partner Violence associated with Disclosure
Model 1a Model 2b Model 3c
OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
At Risk for Clinical Depressiond 1.83 (0.65 – 5.90) 1.70 (0.59 – 5.53) 1.27 (0.43 – 4.27)
Substance Use (Whetten) 3.87 (0.91 – 35.0) 3.72 (0.87 – 33.6) 3.33 (0.77 – 30.2)
a
Model 1: unadjusted
b
Model 2: adjusted for age
c
Model 3: adjusted for age and income
d
Being at risk for clinical depression (CES-D ≥16)
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